Literature DB >> 20561353

Prophylaxis in haemophilia B patients: unresolved issues and pharmacoeconomic implications.

E Santagostino1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20561353     DOI: 10.1111/j.1365-2516.2010.02301.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  2 in total

1.  Prophylaxis use among males with haemophilia B in the United States.

Authors:  M Ullman; Q C Zhang; S D Grosse; M Recht; J M Soucie
Journal:  Haemophilia       Date:  2017-08-06       Impact factor: 4.287

2.  Preclinical evaluation of a next-generation, subcutaneously administered, coagulation factor IX variant, dalcinonacog alfa.

Authors:  Timothy C Nichols; Howard Levy; Elizabeth P Merricks; Robin A Raymer; Martin L Lee
Journal:  PLoS One       Date:  2020-10-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.